Blog
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
Vaxart (NASDAQ: VXRT) soared to stardom when its shares advanced 1,500% last year. Why the excitement?
The biotech company is developing a coronavirus-vaccine candidate in pill form. Investors
The Smartest Stocks to Buy With $500 Right Now
Even a small amount of money allows you to invest in hundreds of stocks in the market, many of which have large growth potential. The difficulty is choosing which ones to invest in.
Both fuboTV
3 Top Warren Buffett Stocks to Buy in October
Warren Buffett is once again doing what he's done throughout much of his career -- beating the market. Shares of his Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) are handily outperforming the S&P
Is Social Security Failing Our Nation's Seniors?
Whether you're already retired or plan to retire at some point in the future, the chances are high that you'll be reliant on Social Security to some varied degree to make ends meet during your
2 No-Brainer Stocks to Buy Now and Hold Forever
Investing ideas can come from many places, but I often start by considering highly impactful global trends. For instance, e-commerce has changed the world, affording consumers convenience, while
Could Social Security Recipients Score Another Stimulus Check?
Back in March, many people enjoyed a $1,400 stimulus check thanks to the American Rescue Plan. But at this point, the likelihood of there being a fourth stimulus check in the near term is low
Is Virgin Galactic Stock Still a Buy?
There are an increasing number of stocks -- especially companies that have gone public via a SPAC merger -- that are extremely long-term bets. It can be OK to take a very small portion of your
Why Investing in Hopes of a Single Outcome Can Be a Huge Mistake
When picking stocks to invest in, it can be easy to gravitate toward a particular narrative. But if that positive narrative hinges on a singular binary outcome (a certain event happens, or it
5 Key Ways Zoom Is Shifting From Merely a Product to a Dominant Platform
Zoom (NASDAQ: ZM) undeniably has a great product. But if it can take that product and expand it into a true platform (or ecosystem), that can mean an amazing future for the company (and its stock).
When a Stock Is Down a Double-Digit Percentage, Should You Buy More or Sell?
It's an immutable fact that the stock market is volatile -- and individual stocks even more so. Stocks can quickly fall in value over short periods of time, sometimes by double-digit percentages
Intuit Is Buying Mailchimp. Here's What Investors Need to Know.
Software giant Intuit (NASDAQ: INTU) recently announced an agreement to buy email marketing platform Mailchimp. This comes shortly after Intuit's sizable acquisition of Credit Karma. In this Fool
Why Investing for a Short-Term Result Is So Hard
When news and media outlets latch on to a story, it's sometimes easy to follow the story and let it dictate your investment decisions. But focusing on the short term can lead to disastrous
Why Unity Stock Looks Like a Smart Buy
Unity Software (NYSE: U) is the company behind one of two major 3D game engines on the market, the other being Epic Games' Unreal engine. However, Unity has established itself as the industry
Why Humana Is Suing Biogen
Biotechs such as Biogen (NASDAQ: BIIB) depend on health insurers like Humana (NYSE: HUM) to cover their drugs. But there can sometimes be a somewhat adversarial relationship between the two sides
3 Must-Dos to Maximize Your Social Security Checks
Want more money from Social Security to help you fund your retirement? There are three steps to take that can help you make that happen -- some of which you'll need to start working on early in your
What Stood Out From Salesforce.com's Investor Day
Salesforce.com's (NYSE: CRM) recent investor day covered how it sees its role in the transformation of businesses into digital-first workplaces, from the integration of recent acquisition Slack to
3 Investors Compare the Market Crash of 2020 With the Market Crash of 2008
Very steep market plunges of 30% or more are rare, but they do happen every decade or so. But the crash of 2020 was different from downturns of times past. Fool.com contributors Jason Hall, Jon
Why Pfizer Will Profit From Merck's Rival Pneumococcal Vaccine
Pfizer (NYSE: PFE) and Merck (NYSE: MRK) compete head-to-head in the pneumococcal vaccine market. While Pfizer's Prevnar 13 remains the best seller, both companies have newer vaccines on the market
How Big Is Zoom's Churn?
Zoom (NASDAQ: ZM) recently shared its churn numbers -- the number of customers it loses over time. In this Backstage Pass video, which aired Sept. 28, 2021, Motley Fool contributor Brian Withers
3 Stocks to Load Up on When the Stock Market Sells Off
Volatility has returned to the stock market in recent weeks, pushing the S&P 500 down more than 5% below its all-time high at one point. While that's not a major sell-off, it's the biggest decline
Why The Holiday Season Could Be Better Than You Think
Supply chain woes and the Delta variant have captured headlines causing some fears that the holiday season could be torched again for retailers.
However, Fool contributors Jeremy Bowman, Brian
3 Heavy Hitters Zoom Is Like: PayPal, Microsoft, and Shopify
Things are generally going well for a company when it's being compared positively to PayPal (NASDAQ: PYPL), Microsoft (NASDAQ: MSFT), and Shopify (NASDAQ: SHOP).
In this Backstage Pass video, which
What Is the Metaverse?
Chances are you've heard a lot of talk about the metaverse. But what does that term mean? And how does it differ from technologies like augmented and virtual reality? In this Backstage Pass video
Where to Invest $5,000 Right Now
Finding the best companies to invest your hard-earned money in isn't always easy. With so many stocks to pick from, finding the right investment choices that align with your portfolio and long-term
2 Beaten-Down Growth Stocks to Buy Hand Over Fist
September wasn't a great month on Wall Street. The S&P 500 dropped almost 5%, and plenty of stocks performed significantly worse. For instance, shares of biotech giant Vertex Pharmaceuticals


